News & Insights
Redefining Cell Therapy Manufacturing:
A Conversation with Bruce Thompson
A Conversation with Bruce Thompson
Building the Next Generation of Cell Therapy Manufacturing
Filmed live at BIO International 2025 in Boston, this exclusive interview with Pharma’s Almanac features Bruce Thompson, Chief Technology Officer at Kincell Bio, as he shares how Kincell is helping reshape the future of cell therapy manufacturing.
In this conversation, Bruce discusses the shifting expectations of today’s advanced therapy developers and how Kincell is building flexible, scalable infrastructure to meet those evolving needs. He emphasizes the importance of personalized partnerships and scientific rigor as critical drivers of successful commercialization, and highlights why aligning CMC strategies with long-term clinical and commercial goals is essential for sustained success in the cell therapy space.
Watch the full interview to see how Kincell Bio is driving what’s next in cell therapy CDMO services.
